Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients.

Elisei, Rossella; Vivaldi, Agnese; Agate, Laura; Molinaro, Eleonora; Nencetti, Chiara; Grasso, Lucia; Pinchera, Aldo; Pacini, Furio

Elisei, Rossella; Vivaldi, Agnese; Agate, Laura; Molinaro, Eleonora; Nencetti, Chiara; Grasso, Lucia; Pinchera, Aldo; Pacini, Furio.

Affiliation

Elisei R; Department of Endocrinology and Metabolism, University of Pisa, 56124 Pisa, Italy. relisei@endoc.med.unipi.it

J Clin Endocrinol Metab ; 89(1): 33-9, 2004 Jan.

Article in En | MEDLINE | ID: mdl-14715824

Subject(s)

Biomarkers, Tumor/genetics; RNA, Messenger/blood; Thyroglobulin/genetics; Thyroid Neoplasms/blood; Biomarkers, Tumor/blood; Enzyme-Linked Immunosorbent Assay; Female; Humans; Luminescent Measurements; Male; Neoplasm Metastasis; Quality Control; Recombinant Proteins; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Thyroglobulin/blood; Thyrotropin

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thyroglobulin / RNA, Messenger / Thyroid Neoplasms / Biomarkers, Tumor Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: J Clin Endocrinol Metab Year: 2004 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links